This study is a registry, meaning it collects information from patients who have already received a treatment called GammaTile (Surgically Targeted Radiation Therapy) for various brain tumors. The goal is to understand how well GammaTile works in a real-world setting and its safety. You may be able to join if you have a brain tumor that has been surgically removed and you have received GammaTile treatment. The study will look at how long patients live, how long they remain free from tumor recurrence around the surgery site, and their quality of life. This study plans to include about 600 participants.

Study design

This is an observational study, meaning researchers will collect data from patients who have already received GammaTile treatment. It aims to include 600 participants.

What's involved

Data will be collected at 1, 3, 6, 9, 12, 18, and 24 months, then every 6 months through 5 years. This includes information on local control, overall survival, quality of life, and side effects.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for up to 5 years after treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.